Characterization of multi-walled carbon nanotubes double-functionalization with cytostatic drug etoposide and phosphorothioate oligodeoxynucleotides

Loading...
Thumbnail Image
Date
2015-09-01
Authors
Heger, Zbyněk
Moulick, Amitava
Nguyen, Hoai Viet
Kremplová, Monika
Kopel, Pavel
Hynek, David
Eckschlager, Tomáš
Stiborová, Marie
Zítka, Ondřej
Adam, Vojtěch
Advisor
Referee
Mark
Journal Title
Journal ISSN
Volume Title
Publisher
ESG
Abstract
Carbon nanomaterials possess unique structural and physicochemical properties, and thus they are broadly utilized as carriers for a variety of therapeutic agents in nanomedicinal applications. Herein we present an electrochemical characterization of binding capability of acidic oxidized multi-walled carbon nanotubes (oMWCNTs) modified with poly(ethylene glycol) towards common cytostatic drug etoposide (or VP-16). The comparison of willingness of oMWCNTs and MWCNTs-PEG to form complexes with etoposide revealed significantly higher capacity in PEGylated variant of carbon nanotubes (the 15 mM etoposide loading capacity was approximately 46.4% in 2 mg of MWCNT-PEG or 28.1% in equal amount of oMWCNT). To obtain a multifunctional nanotransporter we employed the phosphorothioate oligodeoxynucleotide (PODN), which could further extend the possible biological effects of MWCNT-PEG-Etoposide complex. By using square wave voltammetry, the binding capacity of 2 mg of MWCNT-PEG-Etoposide (15 mM) towards PODNs was determined to be 4.5 mu M. Such characterized multifunctional complex can be further employed for biological testing on chemoresistant tumors, such as non-small-cell lung cancer, to enhance the treatment efficiency.
Description
Citation
INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE. 2015, vol. 10, issue 9, p. 7707-7719.
http://www.electrochemsci.org/papers/vol10/100907707.pdf
Document type
Peer-reviewed
Document version
Published version
Date of access to the full text
Language of document
en
Study field
Comittee
Date of acceptance
Defence
Result of defence
Document licence
Creative Commons Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
DOI
Citace PRO